-+ 0.00%
-+ 0.00%
-+ 0.00%

Sana Biotechnology reports Q3 cash position of $153.1 million and focuses pipeline on type 1 diabetes and in vivo CAR T programs

Reuters·11/06/2025 21:21:51

Please log in to view news